(Q34668826)

3 August 2017

6 references

20 June 2019

25 June 2019

22 July 2019

19 September 2019

2 October 2020

20 October 2020

Assessment of vaccine candidates for persons aged 50 and older: a review (English)

1 reference

preventive health services

3 August 2017

main subject

1 reference

biomedical investigative technique

22 July 2019

1 reference

19 September 2019

1 reference

2 October 2020

1 reference

20 October 2020

2

Paul F M Krabbe

1 reference

3 August 2017

6

Hester E de Melker

1 reference

3 August 2017

5

Alies van Lier

1 reference

3 August 2017

Renske Eilers

1

1 reference

3 August 2017

Ted G A van Essen

series ordinal

3

1 reference

3 August 2017

Anita Suijkerbuijk

series ordinal

4

1 reference

3 August 2017

publication date

15 April 2013

7 references

3 August 2017

20 June 2019

25 June 2019

22 July 2019

19 September 2019

2 October 2020

20 October 2020

7 references

3 August 2017

20 June 2019

25 June 2019

22 July 2019

19 September 2019

2 October 2020

20 October 2020

13

1 reference

3 August 2017

page(s)

32

1 reference

Creative Commons Attribution 2.0 Generic

3 August 2017

copyright license

6 references

20 June 2019

25 June 2019

22 July 2019

19 September 2019

2 October 2020

Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands

20 October 2020

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

A critical literature review of health economic evaluations in pertussis booster vaccination

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Immunogenicity and safety of ZOSTAVAX(®) approaching expiry potency in individuals aged ≥50 years

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Immunosenescence: Implications for vaccination programmes in adults.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Update on pertussis and pertussis immunization

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Keeping our adult patients healthy and active: the role of vaccines across the lifespan

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Zoster vaccine: current status and future prospects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Bordetella pertussis strains with increased toxin production associated with pertussis resurgence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Distribution of varicella-zoster virus (VZV) wild-type genotypes in northern and southern Europe: evidence for high conservation of circulating genotypes.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Update on vaccine-preventable diseases: are adults in your community adequately protected?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Vaccines for preventing pneumococcal infection in adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Prevention of herpes zoster and its painful and debilitating complications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

If pneumonia is the "old man's friend", should it be prevented by vaccination? An ethical analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Duration of immunity against pertussis after natural infection or vaccination

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Effectiveness of immune globulins in preventing infectious hepatitis and hepatitis A: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of Life

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Genetic variability of hepatitis A virus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Epidemiology and unique aspects of aging and infectious diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL Cohort.

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

Immunosurveillance and the evaluation of national immunization programmes: a population-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

Nasopharyngeal carriage of Streptococcus pneumoniae and pneumococcal urine antigen test in healthy elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

An epidemic of pertussis among elderly people in a religious institution in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

Influenza- and respiratory syncytial virus-associated mortality and hospitalisations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

Morbidity of pertussis in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

Efficacy of an acellular pertussis vaccine among adolescents and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

Safety and immunogenicity of a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine when co-administered with influenza vaccine in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

Cost effectiveness of pertussis vaccination in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Increase in hepatitis A cases in the Czech Republic in 2008 - an update.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Hepatitis A outbreak in a Roma village in eastern Slovakia, August-November 2008.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Community-wide outbreak of hepatitis A in Latvia, in 2008

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668232

Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands

26 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-32

The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination

21 January 2018

1 reference

12 December 2020

Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome

1 reference

12 December 2020

Time trends in primary-care morbidity, hospitalization and mortality due to pneumonia

1 reference

12 December 2020

Adult immunizations: update on recommendations

1 reference

12 December 2020

Coalition of advocates to vaccinate of Western European citizens aged 60 years and older

1 reference

12 December 2020

Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors

1 reference

12 December 2020

Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trials

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2318-13-32

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference